BCIS ACI 2020: CTO PCI Has No Prognostic Benefit - Is It a Waste of Time & Money?
Published: 07 February 2020
-
Views:
229 -
Likes:
7
-
Views:
229 -
Likes:
7
-
1m 59sPart 1 Introduction and Preliminary Poll Andrew Ladwiniec, Mark Gunning, Daniel J Blackman, James Spratt, Rosemary Swallow, Jonathan Hill
-
10m 32sPart 2 Pro Argument Daniel J Blackman
-
14m 48sPart 3 Contra Argument James Spratt
Overview
This video debate series filmed at the BCIS ACI meeting 2020, examines whether or not CTO PCI has any prognostic benefits. They examine the pros and cons for use and discuss if the advantages outweigh the cost.
Thanks to BCIS for providing this footage
More from this programme
Part 1
Introduction and Preliminary Poll
1 session | |
Introduction and Preliminary Poll | Watch now |
Part 2
Pro Argument
1 session | |
Pro Argument | Watch now |
Part 3
Contra Argument
1 session | |
Contra Argument | Watch now |
Part 4
Panel Discussion
1 session | |
Panel Discussion | Watch now |
Faculty Biographies
Mark Gunning
Interventional Consultant Cardiologist
Dr Mark Gunning is an Interventional Consultant Cardiologist at Royal Stoke University Hospital, Stoke-on-Trent, UK with a specific interest in complex coronary anatomy, coronary calcification and concommitant cardiac and renal disease.
Daniel J Blackman
Interventional Cardiologist
Dr Daniel Blackman has a national and international reputation in trans-catheter aortic valve implantation (TAVI), having trained specialists throughout the UK, Europe, USA and Japan in performing TAVI.
James Spratt
Professor of Interventional Cardiology
Prof James Spratt is a Professor of Interventional cardiology. A high-volume Interventional Cardiologist with an international reputation in complex PCI, with a sub-speciality interest in intravascular imaging and CTO. Widely published within this area and has performed live case demonstrations globally. He is interested in medical education and is the Founder of Optima Education. Prof James Spratt is an editorial board member of Interventional Cardiology: Reviews, Research, Resources (ICR3).
Jonathan Hill
Dr Jonathan Hill qualified from Edinburgh University Medical School in 1992 following pre-clinical training at Cambridge University. He trained in cardiology at The London Chest and St Bartholomew's Hospitals.
In 1999 he was awarded the first National Heart, Lung and Blood Institute Bench to Bedside award and trained in basic science and interventional research within the Cardiovascular Branch of the National Institutes of Health in Bethesda. He completed his interventional cardiology training at the London Chest Hospital.
In 2005 he was appointed as Clinical Senior Lecturer and Consultant Cardiologist at King's College London.
Rosemary Swallow
Consultant Interventional Cardiologist
Dr Rosemary Swallow is a consultant interventional cardiologist at Royal Bournemouth Hospital, Bournemouth, UK.